Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Details)

v3.19.2
Segment Information (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Dec. 31, 2018
Revenues $ 399,727 $ 496,093 $ 683,891 $ 804,006  
Depreciation and amortization 145,989 124,596 284,494 247,975  
Interest expense 8,819 24,932 32,877 261,918  
Net income (loss) (4,438,823) (1,343,815) (8,943,752) (2,894,784)  
Identifiable long-lived tangible assets 8,185,455   8,185,455   $ 8,129,440
Real property operating [Member]          
Revenues 264,889 278,872 531,515 575,495  
Depreciation and amortization 40,780 32,625 81,561 65,249  
Interest expense 8,819 24,932 32,877 261,918  
Net income (loss) (3,690) 5,617 (102,379) (232,083)  
Identifiable long-lived tangible assets 7,810,549   7,810,549   7,898,224
Medical related consulting services-related parties [Member]          
Revenues 111,434 141,996 125,694 141,996  
Depreciation and amortization 4,766 3,991 7,706 7,997  
Interest expense    
Net income (loss) (54,627) 16,456 (244,697) (157,018)  
Identifiable long-lived tangible assets 3,417   3,417   6,852
Development services and sales of developed products [Member]          
Revenues 23,404 75,225 26,682 86,515  
Depreciation and amortization 100,443 87,980 195,853 174,729  
Interest expense    
Net income (loss) (230,406) 196,896 (478,188) (297,028)  
Identifiable long-lived tangible assets 371,489   371,489   $ 224,364
Other [Member]          
Net income (loss) [1] $ (4,150,100) $ (1,168,992) $ (8,118,488) $ (2,208,655)  
[1] The Company does not allocate any interest expense and general and administrative expense of its being a public company activities to its reportable segments as these activities are managed at a corporate level.